Coronary heart disease in women: Battle is won, but the war remains

Minerva Medica

Volumn 98, Issue 5, 2007, Pages 459-478

  Mehta, P K ^a   Wenger, N K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Heart; Hormone replacement therapy; Menopause; Risk factors; Women

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALDOSTERONE RECEPTOR; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CAROTENE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOCOSAHEXAENOIC ACID; ESTROGEN; FIBRINOGEN RECEPTOR ANTAGONIST; FOLIC ACID; GESTAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; NITRATE; OMEGA 3 FATTY ACID; PLACEBO; PYRIDOXINE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SELENIUM; SEROTONIN UPTAKE INHIBITOR; UNINDEXED DRUG;

ALCOHOL CONSUMPTION; ANEMIA; ANGER; ANGIOCARDIOGRAPHY; ARTERY DISEASE; ASTHMA; ATHEROSCLEROSIS; BLOOD CLOT LYSIS; BREAST CANCER; CANCER; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; COUGHING; DEPRESSION; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; EXERCISE ELECTROCARDIOGRAPHY; FAMILY HISTORY; HEART CATHETERIZATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART REHABILITATION; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMMOBILIZATION; INFLAMMATION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MEDICAL EDUCATION; MENOPAUSE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOPENIA; OSTEOPOROSIS; PERCUTANEOUS CORONARY INTERVENTION; POSTMENOPAUSE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP APNEA SYNDROME; SMOKING; SOCIAL STATUS; STROKE; VENOUS THROMBOEMBOLISM; VITAMIN SUPPLEMENTATION;

EID: 37049037268     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (148)

1. Hu FB, Stampfer MJ, Manson JE, Grodstein F, Colditz GA, Speizer FE et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000;343:530-7.
2. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation 1997;96:2468-82.
3. Marrugat J, Sala J, Masia R, Pavesi M, Sanz G, Valle V et al. Mortality differences between men and women following first myocardial infarction. RESCATE Investigators. Recursos Empleados en el Sindrome Coronario Agudo y Tiempo de Espera. JAMA 1998;280: 1405-9.
4. Blumenthal RS, Michos ED, Nasir K. Further improvements in CHD risk prediction for women. JAMA 2007;297:641-3.
5. Michos ED, Vasamreddy CR, Becker DM, Yanek LR, Moy TF, Fishman EK et al. Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J 2005;150:1276-81.
6. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998;316: 1043-7.
7. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 1988;319:1365-9.
8. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B et al. Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med 1993;119:992-1000.
9. Panagiotakos DB, Rallidis LS, Pitsavos C, Stefanadis C, Kremastinos D. Cigarette smoking and myocardial infarction in young men and women: a case-control study. Int J Cardiol 2007;116:371-5.
10. Mason PJ, Manson JE, Sesso HD, Albert CM, Chown MJ, Cook NR et al. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS). Circulation 2004;109:1623-9.
11. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 1989;149:780-8.
12. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
13. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005;294:326-33.
14. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995;332:1758-66.
15. Shammas NW, Lemke JH, Deckert J, Toth PP, McKinney D, Dippel EJ. Gender differences in adhering to national guidelines in a community lipid clinic. Prev Cardiol 2006;9:215-8.
16. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001;104:1108-13.
17. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993;328:1220-5.
18. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
19. Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000;23:962-8.
20. Wenger NK. Coronary heart disease: the female heart is vulnerable. Prog Cardiovasc Dis 2003;46:199-229.
21. Legato MJ, Gelzer A, Goland R, Ebner SA, Rajan S, Villagra V et al. Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 2006;3:131-58.
22. Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 2003;163:1735-40.
23. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971-2000. Ann Intern Med 2007;Vol 147.
24. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005;28: 514-20.
25. Wenger NK. Heightened Cardiovascular Risk in Diabetic Women: Can the Tide Be Turned? Ann Intern Med 2007;147.
26. Chou AF, Scholle SH, Weisman CS, Bierman AS, Correade-Araujo R, Mosca L. Gender disparities in the quality of cardiovascular disease care in private managed care plans. Womens Health Issues 2007;17:120-30.
27. Champney KP, Veledar E, Klein M, Samady H, Anderson D, Parashar S et al. Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over time. Am Heart J 2007;153:970-8.
28. Blair SN, Kohl HW, 3rd, Paffenbarger RS, Jr., Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989;262:2395-401.
29. Sherman SE, D'Agostino RB, Cobb JL, Kannel WB. Physical activity and mortality in women in the Framingham Heart Study. Am Heart J 1994;128:879-84.
30. Al-Khalili F, Janszky I, Andersson A, Svane B, Schenck-Gustafsson K. Physical activity and exercise performance predict long-term prognosis in middle-aged women surviving acute coronary syndrome. J Intern Med 2007;261:178-87.
31. Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991;338:774-8.
32. Church TS, Earnest CP, Skinner JS, Blair SN. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 2007;297:2081-91.
33. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002;347:716-25.
34. Larsson B, Bengtsson C, Bjorntorp P, Lapidus L, Sjostrom L, Svardsudd K et al. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol 1992;135:266-73.
35. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002;162:2074-9.
36. Sanderson BK, Bittner V. Women in cardiac rehabilitation: outcomes and identifying risk for dropout. Am Heart J 2005;150:1052-8.
37. Folsom AR, French SA, Zheng W, Baxter JE, Jeffery RW. Weight variability and mortality: the Iowa Women's Health Study. Int J Obes Relat Metab Disord 1996;20:704-9.
38. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004;109:42-6.
39. Kragelund C, Kober L, Faber J, Steffensen R, Hilde-brandt P. Metabolic syndrome and mortality in stable coronary heart disease: Relation to gender. Int J Cardiol 2007;121: 62-7.
40. Thrainsdottir IS, Hardarson T, Thorgeirsson G, Sigvaldason H, Sigfusson N. Survival and trends of occurrence of left ventricular hypertrophy, gender differences, 1967-92: The Reykjavik Study. J Intern Med 2003;253:418-24.
41. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:57-61.
42. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
43. Ness J, Aronow WS, Newkirk E, McDanel D. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. J Gerontol A Biol Sci Med Sci 2005;60:255-7.
44. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95.
45. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003;108:2769-75.
46. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106:1883-92.
47. Ness RB, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 1993;328:1528-33.
48. Calderon-Margalit R, Friedlander Y, Yanetz R, Deutsch L, Manor O, Harlap S et al. Late stillbirths and long-term mortality of mothers. Obstet Gynecol 2007;109:1301-8.
49. Anderson RN, Smith BL. Deaths: leading causes for 2002. Natl Vital Stat Rep 2005;53:1-89.
50. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-90.
51. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
52. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13.
53. Tolstrup J, Jensen MK, Tjonneland A, Overvad K, Mukamal KJ, Gronbaek M. Prospective study of alcohol drinking patterns and coronary heart disease in women and men. BMJ 2006;332:1244-8.
54. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I et al. Alcohol consumption and mortality among women. N Engl J Med 1995;332:1245-50.
55. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004;79:1036-46.
56. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006;28:596-602.
57. Young T, Hutton R, Finn L, Badr S, Palta M. The gender bias in sleep apnea diagnosis. Are women missed because they have different symptoms? Arch Intern Med 1996;156:2445-51.
58. Sinnott B, Syed I, Sevrukov A, Barengolts E. Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif Tissue Int 2006;78:195-202.
59. Perez-Castrillon JL, Vega G, Abad L, Sanz A, Chaves J, Hernandez G et al. Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 2007;99:903-5.
60. Muzzarelli S, Pfisterer M. Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J 2006;152:991-6.
61. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 2007;49:1362-8.
62. Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, Rogers WJ et al. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol 2004;43:2009-14.
63. Mallik S, Krumholz HM, Lin ZQ, Kasl SV, Mattera JA, Roumains SA et al. Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation 2005;111:271-7.
64. Mallik S, Spertus JA, Reid KJ, Krumholz HM, Rumsfeld JS, Weintraub WS et al. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med 2006;166:876-83.
65. Parashar S, Rumsfeld JS, Spertus JA, Reid KJ, Wenger NK, Krumholz HM et al. Time course of depression and outcome of myocardial infarction. Arch Intern Med 2006;166:2035-43.
66. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
67. Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ et al. Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: the NHLBI-sponsored WISE study. Psychosom Med 2006;68:217-23.
68. Rutledge T, Reis SE, Olson MB, Owens J, Kelsey SF, Pepine CJ et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study. Arch Gen Psychiatry 2006;63:874-80.
69. Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney RM, Burg MM et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005;62:792-8.
70. Krantz DS, Olson MB, Francis JL, Phankao C, Bairey Merz CN, Sopko G et al. Anger, hostility, and cardiac symptoms in women with suspected coronary artery disease: the Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) 2006;15: 1214-23.
71. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999;100:717-22.
72. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007;297:611-9.
73. Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: Results from the Third National Health and Nutrition Examination Survey. Am Heart J 2000;139:446-53.
74. Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty. Eur Heart J 2002;23:726-33.
75. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997;96:412-7.
76. Pandey SN, Vaidya AD, Vaidya RA, Talwalkar S. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality. J Assoc Physicians India 2006;54:769-74.
77. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006;296:2720-6.
78. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 2007;49:1230-50.
79. Onufrak S, Abramson J, Vaccarino V. Adult-onset asthma is associated with increased carotid atherosclerosis among women in the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 2006; in press.
80. Morrison C, Woodward M, Leslie W, Tunstall-Pedoe H. Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register. BMJ 1997;314:541-6.
81. Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation 2006;114:2619-26.
82. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 2005;111:682-96.
83. Sullivan AK, Holdright DR, Wright CA, Sparrow JL, Cunningham D, Fox KM. Chest pain in women: clinical, investigative, and prognostic features. BMJ 1994;308:883-6.
84. Curzen N, Patel D, Clarke D, Wright C, Mulcahy D, Sullivan A et al. Women with chest pain: is exercise testing worthwhile? Heart 1996;76:156-60.
85. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-6.
86. Vaitkevicius P, Wright JG, Fleg JL. Effect of estrogen replacement therapy on the ST-segment response to postural and hyperventilation stimuli. Am J Cardiol 1989;64:1076-7.
87. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick TH. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA 1999;281:524-9.
88. Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 2000;284:1392-8.
89. Morise AP, Diamond GA. Comparison of the sensitivity and specificity of exercise electrocardiography in biased and unbiased populations of men and women. Am Heart J 1995;130:741-7.
90. Roger VL, Jacobsen SJ, Pellikka PA, Miller TD, Bailey KR, Gersh BJ. Gender differences in use of stress testing and coronary heart disease mortality: a population-based study in Olmsted County, Minnesota. J Am Coll Cardiol 1998;32:345-52.
91. Weiner DA, Ryan TJ, McCabe CH, Kennedy JW, Schloss M, Tristani F et al. Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Aurgery Study (CASS). N Engl J Med 1979;301: 230-5.
92. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998;280:913-20.
93. Marwick TH, Anderson T, Williams MJ, Haluska B, Melin JA, Pashkow F et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995;26:335-41.
94. Mieres JH, Shaw LJ, Hendel RC, Miller DD, Bonow RO, Berman DS et al. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease - the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. J Nucl Cardiol 2003;10:95-101.
95. Klem I, Heitner JF, Shah DJ, Sketch MH, Jr., Behar V, Weinsaft J et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006;47:1630-8.
96. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005;46:158-65.
97. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002;360: 743-51.
98. Lagerqvist B, Safstrom K, Stahle E, Wallentin L, Swahn E. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Studv Group Investigators. J Am Coll Cardiol 2001;38:41-8.
99. Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste PM, Cannon CP et al. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 2002;288:3124-9.
100. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005;45:832-7.
101. Daly C, Clemens F, Lopez Sendon JL, Tavazzi L, Boersma E, Danchin N et al. Gender differences in the management and clinical outcome of stable angina. Circulation 2006;113:490-8.
102. Kjeldsen SE, Warnold I, Hansson L. Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study. J Gend Specif Med 2000;3:35-8.
103. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295:306-13.
104. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
105. Olsson G, Oden A, Johansson L, Sjogren A, Rehnqvist N. Prognosis after withdrawal of chronic postinfarction metoprolol treatment: a 2-7 year follow-up. Eur Heart J 1988;9:365-72.
106. Olsson G, Wikstrand J, Warnold I, Manger Cats V, McBoyle D, Herlitz J et al. Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 1992;13:28-32.
107. Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S et al. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MER-IT-HF). Card Electrophysiol Rev 2003;7:264-75.
108. Pitt B, White H, Nicolau J, Martinez F, Gheorghiade M, Aschermann M et al. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol 2005;46: 425-31.
109. Michels KB, Rosner BA, Walker AM, Stampfer MJ, Manson JE, Colditz GA et al. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study. Cancer 1998;83: 2003-7.
110. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 1994;343:1115-22.
111. Grady D, Chaput L, Kristof M. Diagnosis and treatment of coronary heart disease in women: systematic reviews of evidence on selected topics. Evid Rep Technol Assess (Summ) 2003:1-4.
112. Cho L, Topol EJ, Balog C, Foody JM, Booth JE, Cabot C et al. Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent. J Am Coll Cardiol 2000;36:381-6.
113. Boersma E, Harrington RA, Moliterno DJ, White H. Theroux P, Van de Werf F et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002;359:189-98.
114. Mehilli J, Ndrepepa G, Kastrati A, Nekolla SG, Markwardt C, Bollwein H et al. Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction. J Am Coll Cardiol 2005;45:828-31.
115. Wenger NK. Lipid abnormalities in women: data for risk, data for management. Cardiol Rev 2006;14:276-80.
116. Marchioli R, Schweiger C, Tavazzi L, Valagussa F. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto Miocardico. Lipids 2001;36 Suppl:S119-26.
117. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102:2284-99.
118. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9.
119. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;334:1156-62.
120. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:56-65.
121. Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 2002;288:2432-40.
122. Bleys J, Miller ER, 3rd, Pastor-Barriuso R, Appel LJ, Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006;84:880-7;quiz 954-5.
123. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-88.
124. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49-57.
125. Wenger NK. [Menopausal hormone therapy and cardiovascular disease]. Rev Esp Cardiol 2006;59:1058-69.
126. Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006;166:357-65.
127. Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006;355:125-37.
128. Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med 2000;343:8-15.
129. Mortensen OS, Bjorner JB, Newman B, Oldenburg B, Groenvold M, Madsen JK et al. Gender differences in health-related quality of life following ST-elevation myocardial infarction: women and men do not benefit from primary percutaneous coronary intervention to the same degree. Eur J Cardiovasc Prev Rehabil 2007;14:37-43.
130. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J et al. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 1995;75:987-92.
131. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999;341:217-25.
132. Jacobs AK, Kelsey SF, Yeh W, Holmes DR, Jr., Block PC, Cowley MJ et al. Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute. Am J Cardiol 1997;80:979-84.
133. Chandra NC, Ziegelstein RC, Rogers WJ, Tiefenbrunn AJ, Gore JM, French WJ et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med 1998;158: 981-8.
134. Lansky AJ, Hochman JS, Ward PA, Mintz GS, Fabunmi R, Berger PB et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation 2005;111:940-53.
135. Lansky AJ, Pietras C, Costa RA, Tsuchiya Y, Brodie BR, Cox DA et al. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 2005;111:1611-8.
136. Argulian E, Patel AD, Abramson JL, Kulkarni A, Champney K, Palmer S et al. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol 2006;98:48-53.
137. Narins CR, Ling FS, Fischi M, Peterson DR, Bausch J, Zareba W. In-hospital mortality among women undergoing contemporary elective percutaneous coronary intervention: a reexamination of the gender gap. Clin Cardiol 2006;29:254-8.
138. Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 1998;66:125-31.
139. Kennedy JW, Killip T, Fisher LD, Alderman EL, Gillespie MJ, Mock MB. The clinical spectrum of coronary artery disease and its surgical and medical management, 1974-1979. The Coronary Artery Surgery study. Circulation 1982;66:11116-23.
140. Katircibasi MT, Kocum HT, Baltali M, Erol T, Tekin A, Yigit F et al. Effect of female gender on the outcome of coronary artery bypass surgery for left main coronary artery disease. Anadolu Kardiyol Derg 2007;7:134-9.
141. Vaccarino V, Lin ZQ, Kasl SV, Mattera JA, Roumanis SA, Abramson JL et al. Gender differences in recovery after coronary artery bypass surgery. J Am Coll Cardiol 2003;41:307-14.
142. Basaran M, Selimoglu O, Ozcan H, Ogus H, Kafali E, Ozcelebi C et al. Being an elderly woman: is it a risk factor for morbidity after coronary artery bypass surgery? Eur J Cardiothorac Surg 2007;32:58-64.
143. Humphries KH, Gao M, Pu A, Lichtenstein S, Thompson CR. Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004). J Am Coll Cardiol 2007;49:1552-8.
144. Sharoni E, Song HK, Peterson RJ, Guyton RA, Puskas JD. Off pump coronary artery bypass surgery for significant left ventricular dysfunction: safety, feasibility, and trends in methodology over time - an early experience. Heart 2006;92:499-502.
145. Puskas JD, Thourani VH, Marshall JJ, Dempsey SJ, Steiner MA, Sammons BH et al. Clinical outcomes, angiographic patency, and resource utilization
146. Jackson L, Leclerc J, Erskine Y, Linden W. Getting the most out of cardiac rehabilitation: a review of referral and adherence predictors. Heart 2005;91: 10-4.
147. Bjarnason-Wehrens B, Grande G, Loewel H, Voller H, Mittag O. Gender-specific issues in cardiac rehabilitation: do women with ischaemic heart disease need specially tailored programmes? Eur J Cardiovasc Prev Rehabil 2007;14:163-71.
148. Puskas JD, Kilgo PD, Kutner M, Pusca SV, Lattouf OM, Guyton RA. Off-pump techniques disproportionately benefit women and narrow the gender disparity in outcomes after coronary artery bypass surgery. Circulation 2007 (In press).